Clinical Trial Update: Risk Adapted Therapy in Diffuse Large B Cell Lymphoma [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial evaluating risk-adapted therapy for diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Mansoura University | Conditions: Large B Cell Lymphoma | Phase 2 | Status: UNKNOWN